USPTO trademark

ERBITUX CETUXIMAB

CancelledUSPTOWord and designClass 5

"ERBITUX CETUXIMAB" is a word and design mark owned by ImClone Systems Incorporated, filed at the USPTO on September 10, 2002. It was cancelled and covers class 5 (Pharmaceuticals).

Get this data via the API

Data current as of March 16, 2016Official USPTO record

As filed with the USPTO

Status: Cancelled; Since October 10, 2014
Filed: September 10, 2002
Registered: March 4, 2008
Expires: Not recorded
Application no.: 76463019
Registration no.: 3392234
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 1 class

Ownership

Who owns ERBITUX CETUXIMAB

The owner and representative on file with the office.

Owner

ImClone Systems Incorporated

New York, United States

Representative

Robert E. Lee, Jr.

Eli Lilly and Company

Goods and services

What the mark covers

The products and services ERBITUX CETUXIMAB is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
PHARMACEUTICAL PREPARATION, NAMELY, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 10, 2014Cancelled sec. 8 (6-yr)
June 3, 2009Attorney/dom.rep.revoked and/or appointed
June 3, 2009Teas revoke/app/change addr of atty/dom rep received
February 4, 2009Assignment of ownership not updated automatically
March 21, 2008Teas change of correspondence received
March 4, 2008Registered-principal register
January 28, 2008Law office registration review completed
January 25, 2008Allowed principal register - sou accepted
January 25, 2008Examiners amendment mailed
January 24, 2008Examiner's amendment entered

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

opposition91158375OtherOctober 29, 2003

FAQ

About ERBITUX CETUXIMAB

Who owns the trademark "ERBITUX CETUXIMAB"?

The USPTO trademark "ERBITUX CETUXIMAB" (application 76463019) is owned by ImClone Systems Incorporated.

What is the status of "ERBITUX CETUXIMAB"?

Its status at the USPTO is: cancelled.

When was "ERBITUX CETUXIMAB" registered?

It was registered on March 4, 2008.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ERBITUX CETUXIMAB and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d1f10-024b-75c4-a6f9-69ac41e61dab
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d1f10-024b-75c4-a6f9-69ac41e61dab",
  "object": "trademark",
  "mark_text": "ERBITUX CETUXIMAB",
  "status": {
    "primary": "inactive",
    "stage": "cancelled"
  },
  "office_code": "US",
  "application_number": "76463019",
  "filing_date": "2002-09-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "ImClone Systems Incorporated",
      "entity_id": null
    }
  ]
}